Exosens Shares Surge 6.6% to €65.45, Marking a 73% Increase Over the Year
Exosens shares jumped 6.6% to €65.45 at midday this Thursday, among the highest gains in the SBF 120, which is up 0.41%. The specialist in night vision and imaging technologies for defense has thus erased the decline accumulated at the beginning of May and is approaching its technical resistance. This movement comes on the eve of the annual general meeting scheduled for May 22.
A Rebound That Propels the Share Near Its €67.10 Resistance
Exosens shares have recovered 15.23% over the week and now show a gain of 73.15% over the year. The share price has significantly surpassed its MM20 (€61.69) and MM50 (€63.83), with a 26% gap from the MM200 at €51.79, confirming the underlying bullish trend. The RSI at 49 remains neutral, indicating that the day's rise does not push the share into an overheated zone. The price is now approaching the identified resistance at €67.10, whose crossing would mark a technical breakthrough. The session places Exosens in second place for gains in the SBF 120, behind Eutelsat.
Doubling of Cooled Infrared Camera Production by 2026
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The company announced on Wednesday the doubling of its production capacity for cooled infrared cameras by the year 2026. This ramp-up meets the global demand for imaging solutions used in long-range anti-drone systems and surveillance. The announcement follows the commercial momentum already evident in the first quarter results released at the end of April, which showed a 19.7% increase in revenue to €122.6 million and an adjusted gross margin increase of 20.1%. The next concrete appointment for shareholders is the annual general meeting on May 22, 2026.
Porté par une dynamique commerciale soutenue, en particulier sur les marchés de la Défense et de la Surveillance, ainsi que par une solide exécution opérationnelle
Risks mentioned
Charge de dépréciation de la marque de 28,2 M€ pesant sur le résultat net publié, en baisse de 45,0 %
Incertitudes persistantes sur la recherche scientifique pesant sur la demande en Sciences de la Vie
Contraction de 60 points de base de la marge brute du segment Détection & Imagerie (mix produits)
Opportunities identified
Attribution par l'US Army du contrat IDIQ BiNOD ouvrant le marché américain de la défense
Plan d'expansion de +40 % des capacités de production d'ici 2027, premiers bénéfices au S2 2026
Acquisition d'Emberion, capteurs infrarouges SWIR à points quantiques
Outlook / guidance
Expected revenue: 530 millions d'euros
Expected EBITDA: 173 millions d'euros
Management commentary: chiffre d'affaires compris entre 520 millions d'euros et 540 millions d'euros ; • EBITDA ajusté compris entre 168 millions d'euros et 178 millions d'euros
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
